Researcher
Veerle SOMERS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, General diagnostics, Adaptive immunology, Musculo-skeletal systems, Developmental neuroscience
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From11 Dec 2003 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From16 Jan 2003 → Today - Immunology - Biochemistry (Research group)
Member
From11 Dec 2003 → 31 Dec 2019 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From16 Jan 2003 → 30 Sep 2009
Projects
1 - 10 of 48
- Francqui Chair prof. dr. SwinnenFrom1 Oct 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Novel antibody biomarkers for the prediction of response to first-line therapy in rheumatoid arthritisFrom15 Jan 2023 → 14 Jan 2024Funding: IOF - technology concept exploration
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Anti-UH-RA antibody reactivity for prediction of response to first-line therapy in rheumatoid arthritis: validation in the independent CAP48 cohort.From1 Oct 2022 → 1 Dec 2023Funding: Foundations, funds and other with scientific goal
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- The MIF-CD74 system as a driver of pro-inflammatory B cell responses following traumatic spinal cord injury (SCI).From1 Oct 2021 → TodayFunding: BOF - doctoral mandates
- Elucidating the role of double homeobox protein 4 (DUX4) in the pathology of inflammatory arthritisFrom1 Jan 2021 → 31 Dec 2021Funding: Foundations, funds and other with scientific goal
- Understanding how B cell depletion with ocrelizumab affects the immune system in the treatment of MSFrom1 Jan 2021 → 30 Jun 2023Funding: Foundations, funds and other with scientific goal
- Spinal cord injury induced autoantibodies as biomarkers for patient stratificationFrom1 Nov 2020 → 31 Oct 2022Funding: FWO Strategic Basic Research Grant
- Protective versus damaging aspects of the immune reaction in relation to clinical outcome in the Limburg COVID-19 cohortFrom15 Jun 2020 → 14 Jun 2022Funding: BOF - projects
Publications
41 - 50 of 130
- Photobiomodulation prevents acute radiodermatitis: final results of a RCT in bre ast cancer patients(2018)
Authors: Jolien ROBIJNS, S. Censabella, S. Claes, L. Pannekoeke, L. Busse, I. Kaminksi, D. Colson, Annelies MAES, Paul BULENS, L. Noe, et al.
Pages: S49 - S49 - AUTOANTIBODIES TO TWO NOVEL PEPTIDES IN SERONEGATIVE AND EARLY RHEUMATOID ARTHRITIS IN THREE LARGE INDEPENDENT COHORTS(2018)
Authors: Liesbeth DE WINTER, Patrick VANDORMAEL, V. Stouten, H. W. van Steenbergen, Piet GEUSENS, J. Lenaerts, A. H. M. van der Helm-van Mil, P. Verschueren, Veerle SOMERS
Pages: 842 - 842 - Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients(2018)
Authors: Gwendoline MONTES DIAZ, Judith FRAUSSEN, Bart VAN WIJMEERSCH, R. Hupperts, Veerle SOMERS
- Photobiomodulation therapy prevents severe acute radiodermatitis: a randomized, placebo-controlled trial in breast cancer patients with clinical and objective outcome measures(2018)
Authors: Jolien ROBIJNS, S. Censabella, S. Claes, L. Pannekoeke, L. Bussé, D. Colson, I. Kaminksi, Paul BULENS, Annelies MAES, L. Noé, et al.
Pages: S47 - S47 - Biophysical skin measurements to evaluate the effectiveness of photobiomodulation therapy in the prevention of acute radiation dermatitis in breast cancer patients(2018)
Authors: Jolien ROBIJNS, S. Censabella, S. Claes, L. Pannekoeke, L. Bussé, D. Colson, I. Kaminski, Joy LODEWIJCKX, Paul BULENS, Annelies MAES, et al.
Pages: 1245 - 1254 - SCREENING FOR ANTIBODY REACTIVITY IN EARLY AXIAL SPONDYLOARTHRITIS IDENTIFIES NOVEL ANTIGENIC TARGETS(2018)
Authors: Dana QUADEN, Patrick VANDORMAEL, Kristoff CORTEN, Frank VANDENABEELE, Johan VANHOOF, Piet GEUSENS, Veerle SOMERS
Pages: 737 - 737 - Interrelation of Diet, Gut Microbiome, and Autoantibody Production(2018)
Authors: Ioanna PETTA, Judith FRAUSSEN, Veerle SOMERS, Markus KLEINEWIETFELD
Pages: 1 - 9 - Twelve Weeks of Medium-Intensity Exercise Therapy Affects the Lipoprotein Profile of Multiple Sclerosis Patients.(2018)
Authors: Winde JORISSEN, Tim VANMIERLO, Inez WENS, Veerle SOMERS, Bart VAN WIJMEERSCH, Jeroen BOGIE, Alan Remaley, Bert OP 'T EIJNDE, Jerome HENDRIKS
Pages: 1 - 11 - Novel Antibody Targets in Spinal Cord Injury: Study of their Biomarker Potential and Biological Relevance(2018)
Authors: Ilse PALMERS, Veerle SOMERS
Number of pages: 178 - THE USE OF PHOTOBIOMODULATION THERAPY FOR THE MANAGEMENT OF ORAL MUCOSITIS IN CANCER PATIENTS OTHER THAN HEAD AND NECK CANCER: TWO RETROSPECTIVE ANALYSES(2017)
Authors: Jolien ROBIJNS, Sandrine Censabella, Lien Holvoet, Leen Noe, Marc Brosens, Annelies MAES, Paul BULENS, Daisy Luyten, Eric Joosens, Niels HELLINGS, et al.
Pages: 52 - 52
Patents
1 - 9 of 9
- Method and means for diagnosis of spondyloarthritis (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)
Linked dataset
1 - 1 of 1